Save
The Evolution in CAT treatment: Digesting New DOACs Studies Data
ISTH Academy, Cihan Ay & Marc Carrier, 223428
Archived Webinar: Considering Patient Profile in VTE Extended Anticoagulation: Applying Evidence to Clinical Practice
ISTH Academy, Scott Stevens & Gregory Piazza, 223425
Diagnose and manage patients with immune thrombocytopenia (ITP) applying indications for treatment and treatment options
ISTH Academy, ISTH, 120241
Relate the principles of the structural and functional aspects of the biology of factor VIII (FVIII) and factor IX (FIX) to clinical management of patients with haemophilia A or B
ISTH Academy, ISTH, 120250
Recognize clinical manifestations of haemophilia
ISTH Academy, ISTH, 120251
Diagnose haemophilia A and B by interpreting laboratory tests
ISTH Academy, ISTH, 120252
Perform laboratory tests for diagnosis of haemophilia A and B
ISTH Academy, ISTH, 120253
Relate the principles of the epidemiology, immunology and molecular basis of inhibitors to FVIII, or FIX to clinical management of patients with haemophilia A or B
ISTH Academy, ISTH, 120255
Diagnose patients with inhibitors to FVIII and FIX by interpreting laboratory tests
ISTH Academy, ISTH, 120256
Manage dosing regimens for immune tolerance induction in patients with inhibitors, as well as in the use of immunosuppressive drugs, apheresis and immunoadsorption
ISTH Academy, ISTH, 120259
Provide management plans for physiotherapists for prevention and treatment of arthropathy in haemophilia patients
ISTH Academy, ISTH, 120262
Provide advice for management of haemostasis in symptomatic carriers of haemophilia A and B requiring surgery
ISTH Academy, ISTH, 120263
Appreciate the issues relating to the provision of haemophilia care in different parts of the world and the difficulties of providing diagnostic and therapeutic services in some countries
ISTH Academy, ISTH, 120266
Diagnose and classify VWD by interpretation of laboratory tests
ISTH Academy, ISTH, 120271
Perform laboratory tests for diagnosis and classification of VWD
ISTH Academy, ISTH, 120272
Develop clinical management plans for patients with VWD
ISTH Academy, ISTH, 120273
Manage treatment of bleeds in patients with VWD, including use of desmopressin acetate, FVIII/VWF concentrates, cryoprecipitate, antifibrinolytics and fibrin glue
ISTH Academy, ISTH, 120274
Diagnose and treat patients with VWD and inhibitors
ISTH Academy, ISTH, 120275
Diagnose and manage patients with superficial venous thrombosis
ISTH Academy, ISTH, 120298
Diagnose and manage patients with thrombosis due to antiphospholipid syndrome
ISTH Academy, ISTH, 120299
Develop and apply recommendations for thromboprophylaxis, including mechanical and pharmacological interventions, in patients at risk of venous thromboembolism e.g. peri-operative and post-traumatic period, and other periods of immobility
ISTH Academy, ISTH, 120303
Investigate women for relevant haemostatic factors involved in placenta-mediated pregnancy complications (preeclampsia, fetal loss, stillbirth, placental abruption)
ISTH Academy, ISTH, 120325
Assess and manage gynaecological and obstetric issues in women with inherited bleeding disorders
ISTH Academy, ISTH, 120328
Manage haematological aspects of postpartum haemorrhage
ISTH Academy, ISTH, 120329
The Burden of Hospital-Associated VTE: Facts Every Clinician Should Know
ISTH Academy, ISTH Academy, 227662
Preventing Thrombosis During and Post-Hospitalization: New Paradigms in Clinical Care
ISTH Academy, ISTH Academy, 227661
Ranking the stars
ISTH Academy, Session Speakers, 234149
Factor XI promotes hemostasis in factor IX‐deficient mice
ISTH Academy, David Gailani, 234150
The next best thing in factor VIIa
ISTH Academy, Maureane Hoffman, 234151
Genome‐wide analysis of genetic determinants of circulating factor VII‐activating protease (FSAP) activity
ISTH Academy, Maja Olsson, 234152
The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism
ISTH Academy, Gualtiero Palareti, 234153
Nano‐evidence for joint microbleeds in hemophilia patients
ISTH Academy, John Puetz, 234154
The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTH
ISTH Academy, Alberto Tosetto, 234155
Mortality due to bleeding, myocardial infarction and stroke in dialysis patients
ISTH Academy, G. Ocak, 234156
Laboratory criteria for antiphospholipid syndrome: reply
ISTH Academy, Katrien Devreese, 234157
Stay Coagulated and Join the ISTH Today
ISTH Academy, Session Speakers, 234158
Use of factor concentrates for the management of perioperative bleeding: reply
ISTH Academy, Anne Godier, 234159
Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism
ISTH Academy, Aaron R. Folsom, 234160
Laboratory criteria for antiphospholipid syndrome: comment
ISTH Academy, Karl Lackner, 234161
Local chromatin interactions contribute to expression of the fibrinogen gene cluster
ISTH Academy, Marguerite Neerman-Arbez, 234162
Cerebral venous sinus thrombosis
ISTH Academy, Ida Martinelli, 234163
Heparin–protamine balance after neonatal cardiopulmonary bypass surgery
ISTH Academy, Alan Mast, 234164
Small molecule targeting the Rac1‐NOX2 interaction prevents collagen‐related peptide and thrombin‐induced reactive oxygen species generation and platelet activation
ISTH Academy, Huzoor Akbar, 234165
What the neighbors say
ISTH Academy, Session Speakers, 234166
The chaperone‐like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation
ISTH Academy, Alessio Branchini, 234167
Identification of high thrombotic risk triple‐positive antiphospholipid syndrome patients is dependent on anti‐cardiolipin and anti‐β2glycoprotein I antibody detection assays
ISTH Academy, Katrien Devreese, 234168
Issue Information
ISTH Academy, Session Speakers, 234169
Delimiting the autoinhibitory module of von Willebrand factor
ISTH Academy, Wei Deng, 234170
Tissue factor at the crossroad of coagulation and cell signaling
ISTH Academy, Wolfram Ruf, 234171
Phase 1, single‐dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia
ISTH Academy, Ralph A. Gruppo, 234172
Weight‐adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery
ISTH Academy, Deborah Siegal, 234173
Use of factor concentrates for the management of perioperative bleeding: comment
ISTH Academy, Nigel Sargant, 234174
Venous thromboembolism in patients with liver diseases
ISTH Academy, Raquel Barba, 234175
Fibrinolysis: strategies to enhance the treatment of acute ischemic stroke
ISTH Academy, Paul Y. Kim, 234176
Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin‐activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different in vitro models
ISTH Academy, D. Hendriks, 234177
Assessment of whole blood coagulation with a microfluidic dielectric sensor
ISTH Academy, Pedram Mohseni, 234178
Pediatric Thrombosis
ISTH Academy, Mary Bauman & Sophie Jones, 223426
Perioperative Management of Patients who are Receiving Anticoagulant Therapy
ISTH Academy, James Douketis & Deborah Siegal, 228093
Targeting platelet EPCR for better therapeutic factor VIIa activity
ISTH Academy, Steven Lentz, 230955
Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study
ISTH Academy, Katharine L. Cheung, 230956
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults
ISTH Academy, Guillaume Moulis, 230957
Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N‐oxide‐generating pathway, modulates platelet responsiveness and thrombosis risk
ISTH Academy, Stanley L. Hazen, 230958
Leukocytes as a reservoir of circulating oncogenic DNA and regulatory targets of tumor‐derived extracellular vesicles
ISTH Academy, Janusz Rak, 230959
PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway: reply
ISTH Academy, Matthew Rondina, 230960
Acquired platelet antagonism: off‐target antiplatelet effects of malignancy treatment with tyrosine kinase inhibitors
ISTH Academy, Marijke Kuijpers, 230961
What the neighbors say
ISTH Academy, Session Speakers, 230962
A first‐in‐human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of PF‐06741086, an anti‐tissue factor pathway inhibitor mAb, in healthy volunteers
ISTH Academy, Matthew Cardinal, 230963
Discovery of novel plasma biomarkers for future incident venous thromboembolism by untargeted synchronous precursor selection mass spectrometry proteomics
ISTH Academy, Søren Beck Jensen, 230964
Human platelets express endothelial protein C receptor, which can be utilized to enhance localization of factor VIIa activity
ISTH Academy, Ammon M. Fager, 230965
Substantial recurrence risk after venous thromboembolism provoked by minor risk factors
ISTH Academy, Sigrid Braekkan, 230966
Issue Information
ISTH Academy, Session Speakers, 230967
Thrombopoietin receptor agonists in hereditary thrombocytopenias
ISTH Academy, Francesco Rodeghiero, 230968
Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH
ISTH Academy, Alessandro Casini, 230969
Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism
ISTH Academy, Menno Huisman, 230970
Stay Coagulated and Join the ISTH Today
ISTH Academy, Session Speakers, 230971
Autoantibody against integrin αβ contributes to thrombocytopenia by blocking the migration and adhesion of megakaryocytes
ISTH Academy, Junping Wang, 230972
Tuning the endothelial response: differential release of exocytic cargos from Weibel‐Palade bodies
ISTH Academy, Daniel Cutler, 230973
Chemical and pharmacological aspects of neutralization of heparins from different animal sources by protamine
ISTH Academy, Paulo A. S. Mourão, 230974
Alcohol consumption and the risk of incident pulmonary embolism in US women and men
ISTH Academy, Laura B. Harrington, 230975
Learning by counting blood platelets in population studies: survey and perspective a long way after Bizzozero
ISTH Academy, Chiara Cerletti, 230976
Predators
ISTH Academy, Session Speakers, 230977
The pediatric acenocoumarol dosing algorithm: the Children Anticoagulation and Pharmacogenetics Study
ISTH Academy, Anthonius de Boer, 230978
PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway: comment
ISTH Academy, Ulhas Naik, 230979
Hereditary angioedema: the plasma contact system out of control
ISTH Academy, Coen Maas, 230980
Anti‐C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model
ISTH Academy, Shannon L. Meeks, 230981
Role of direct oral anticoagulants in the treatment of cancer‐associated venous thromboembolism: guidance from the SSC of the ISTH
ISTH Academy, Alok A. Khorana, 230982
The use of platelets in regenerative medicine and proposal for a new classification system: guidance from the SSC of the ISTH
ISTH Academy, Paul Harrison, 230983
Hemostatic complications in patients on ECMO and VADs
ISTH Academy, Jean Conners & Katherine Regling, 223424
McMaster RARE‐Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome
ISTH Academy, Kimberly Legault, 227420
Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti‐factor IXa/factor X bispecific antibody emicizumab: comment
ISTH Academy, Hideo Wada, 227421
In‐depth comparison of N‐glycosylation of human plasma‐derived factor VIII and different recombinant products: from structure to clinical implications
ISTH Academy, Birgit M. Reipert, 227422
Clinical and economic impact of compression in the acute phase of deep vein thrombosis
ISTH Academy, Elham E. Amin, 227423
Elevated plasma levels of P‐selectin glycoprotein ligand‐1‐positive microvesicles in patients with unprovoked venous thromboembolism
ISTH Academy, John-Bjarne Hansen, 227424
Hemorrhagic disorders of fibrinolysis: a clinical review
ISTH Academy, Joline Lieke Saes, 227425
Pleiotropic effects of the hemostatic system
ISTH Academy, Henri Spronk, 227436
Hollow organosilica beads as reference particles for optical detection of extracellular vesicles
ISTH Academy, Zoltan Varga, 227437
Issue Information
ISTH Academy, Session Speakers, 227438
Reduction in physical function in women after venous thromboembolism
ISTH Academy, Kaitlin A Hagan, 227439
An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS‐VWF study
ISTH Academy, Imre Bodó, 227440
Carboxypeptidase B2 and carboxypeptidase N in the crosstalk between coagulation, thrombosis, inflammation, and innate immunity
ISTH Academy, John Morser, 227441

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings